Protalix BioTherapeutics
PLX
#7922
Rank
HK$1.81 B
Marketcap
HK$22.55
Share price
2.00%
Change (1 day)
140.02%
Change (1 year)

Earnings for Protalix BioTherapeutics (PLX)

Earnings in 2024 (TTM): HK$40.17 Million

According to Protalix BioTherapeutics 's latest financial reports the company's current earnings are HK$53.39 Million. a decrease over its 2023 earnings that were of HK$91.16 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Protalix BioTherapeutics from 1999 to 2024

Annual earnings

Year Earnings Change
2024 HK$40.45 M-55.62%
2023 HK$91.16 M-199.05%
2022 -HK$92.05 Million-40.38%
2021 -HK$0.16 Billion-732.31%
2020 HK$24.41 M-130.53%
2019 -HK$79.97 Million189.85%
2018 -HK$27.59 Million-95.29%
2017 -HK$0.59 Billion308.12%
2016 -HK$0.15 Billion-32.37%
2015 -HK$0.22 Billion10.11%
2014 -HK$0.2 Billion-7.59%
2013 -HK$0.21 Billion
2011 -HK$0.25 Billion-19.39%
2010 -HK$0.3 Billion20.87%
2009 -HK$0.25 Billion32.26%
2008 -HK$0.19 Billion-5.46%
2007 -HK$0.2 Billion
2004 -HK$1.29 Million12.35%
2003 -HK$1.15 Million-11.1%
2002 -HK$1.29 Million-57.03%
2001 -HK$3 Million1.03%
2000 -HK$2.97 Million-53.22%
1999 -HK$6.34 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
-HK$0.23 Billion-651.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$3.98 B 9,740.87%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$86.19 B 212,955.98%๐Ÿ‡บ๐Ÿ‡ธ USA
-HK$2.19 Billion-5,506.44%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel